≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm: Other parts of oropharynx

DOID Endpoint Browser PheWeb

CD2_BENIGN_OROPHA_OTHER

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D10.5&
  • Hospital discharge: ICD-9 — 2106
  • Hospital discharge: ICD-8 — 2106
  • Cause of death: ICD-10 — D10.5&
  • Cause of death: ICD-9 — 2106
  • Cause of death: ICD-8 — 2106

2 out of 7 registries used, show all original rules.

324

4. Check minimum number of events

None

324

5. Include endpoints

None

324

6. Filter based on genotype QC (FinnGen only)

324

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D10
Name in latin
Neoplasma benignum oropharyngis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2025 1071 939
Only index persons 1865 1002 863
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.03
Only index persons 0.04 0.04 0.03
Median age at first event (years)
Whole population 51.53 52.28 50.52
Only index persons 50.66 51.48 49.72

-FinnGen-

Key figures

All Female Male
Number of individuals 324 193 131
Unadjusted period prevalence (%) 0.06 0.07 0.06
Median age at first event (years) 52.67 51.17 54.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
290
Matched controls
2901
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
+∞
323.0
274
*
ENA10
NOMESCO Finland
Biopsy of pharynx
471.5
42.3
41
*
UJC01
NOMESCO Finland
Scopy of lower throat
24.7
19.5
27
12
EHA10
NOMESCO Finland
Biopsy of palate
33.8
17.3
22
7
EHB00
NOMESCO Finland
Excision of lesion of palate
79.0
13.7
15
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
13.5
11.3
19
15
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.8
10.8
36
83
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
41.6
10.0
12
*
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
103.3
9.5
10
*
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
12.0
9.2
16
14
EMA10
NOMESCO Finland
Biopsy of tonsil
+∞
8.4
8
*
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
8.4
8
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.8
8.4
35
101
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
10.5
8.1
15
15
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
46.2
7.8
9
*
GBB00
NOMESCO Finland
Tracheostomy
13.8
7.4
12
9
2106A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Other parts of oropharynx
+∞
7.3
7
*
G47.3
ICD-10 Finland
Sleep apnoea
2.3
7.0
75
389
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.8
6.8
28
80
PA7BD
NOMESCO Finland
CT angiography of neck and brain
17.2
6.8
10
6
D10.39
ICD-10 Finland
Benign tumor in other or unspecified part of oral cavity UNS
41.0
6.8
8
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
10.4
6.6
12
12
R21
ICPC
Throat symptom/complaint
2.3
6.5
66
334
JDB10
NOMESCO Finland
Percutaneous gastrostomy
9.6
6.3
12
13
21068
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Other parts of oropharynx
+∞
6.3
6
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
6.0
100
617

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
184
1099
2.56
15.32
2.5
2.0
—
—
—
0
0
166
1108
2.02
8.81
5.5
4.6
35.7
35.8
g/l
0.09
157
1045
137
864
2.01
8.44
5.6
5.6
—
—
—
0
0
55
247
2.48
7.82
1.4
1.4
—
—
—
0
0
62
307
2.26
7.05
2.1
1.6
—
—
—
0
0
253
2086
1.97
6.00
8.4
7.5
77.4
78.0
u/l
0.09
241
1946
29
111
2.77
5.65
1.3
1.2
—
—
—
0
0
173
1288
1.74
5.59
3.9
4.0
—
—
—
0
0
201
1567
1.74
5.45
6.0
4.9
6.6
6.6
mmol/l
0.12
185
1447
183
1395
1.72
5.33
6.3
5.9
0.2
0.2
e9/l
0.44
158
1235
200
1564
1.73
5.29
9.6
9.3
4.1
4.1
e9/l
0.25
167
1374
164
1219
1.70
5.20
5.8
5.8
0.7
0.7
%
0.30
152
1141
127
881
1.73
5.19
3.8
3.5
2.4
2.3
mmol/l
0.22
113
783
169
1270
1.69
5.12
8.5
7.1
1.2
1.2
mmol/l
0.77
143
1070
168
1261
1.69
5.11
5.7
5.7
2.6
2.8
%
0.71
155
1183
168
1266
1.68
4.99
5.9
6.0
8.5
8.6
%
0.09
155
1197
177
1353
1.68
4.97
5.6
5.6
0.0
0.0
e9/l
0.48
145
1169
249
2090
1.83
4.97
4.7
3.9
14.7
14.7
pmol/l
0.03
224
1894
35
159
2.35
4.83
3.7
3.9
4.5
4.6
pmol/l
0.27
28
142
142
1032
1.67
4.79
13.1
7.4
1.3
1.2
inr
0.51
37
316
224
1836
1.71
4.72
4.9
4.2
—
—
—
0
0
175
1346
1.65
4.70
5.6
5.5
0.6
0.6
e9/l
0.18
145
1165
241
2019
1.76
4.65
4.5
4.0
11.4
11.3
mm/h
0.04
225
1853
139
1023
1.63
4.36
2.1
1.9
91.3
95.0
pmol/l
0.52
67
526
182
1434
1.61
4.29
7.0
6.1
10.9
10.9
umol/l
0.00
176
1362
168
1299
1.61
4.28
5.8
5.8
26.7
28.3
%
0.92
154
1222
89
587
1.71
4.23
1.8
1.7
1.9
1.2
mg/l
0.50
67
466
177
1389
1.60
4.21
5.7
5.6
1.9
2.0
e9/l
0.16
152
1232
165
1283
1.58
4.01
5.7
5.6
58.8
57.0
%
1.14
151
1213
303
2774
2.42
3.95
21.6
15.4
139.6
139.7
mmol/l
0.49
298
2690
303
2783
2.37
3.76
21.9
15.4
3.9
4.0
mmol/l
3.66
297
2698
282
2528
1.89
3.69
5.8
4.6
2.0
2.3
mu/l
0.31
258
2302
298
2727
2.16
3.60
20.4
13.6
21.2
22.6
mg/l
0.31
260
2135
104
743
1.59
3.54
2.8
3.0
0.6
0.4
e6/l
0.41
74
545
108
779
1.58
3.53
4.4
3.7
—
—
—
0
0
60
372
1.75
3.52
1.4
1.2
—
—
—
0
0
76
506
1.66
3.43
2.4
2.7
522.8
548.8
mosm/kgh2o
0.41
60
428
74
490
1.66
3.41
3.5
3.4
141.7
290.8
ng/l
0.56
54
357
150
1171
1.52
3.41
7.2
6.4
1.2
1.2
mmol/l
0.05
138
1072
220
1868
1.55
3.35
4.2
3.7
—
—
—
0
0
108
788
1.56
3.33
1.5
1.4
—
—
—
0
0
277
2490
1.78
3.32
20.7
14.2
39.6
40.2
%
0.54
192
1854
108
789
1.55
3.31
4.8
4.1
7.4
7.4
ph
0.78
21
152
151
1188
1.51
3.27
10.3
9.4
0.0
0.0
e9/l
1.02
114
973
109
806
1.53
3.14
2.8
3.1
21.3
134.3
e6/l
0.78
82
609
71
478
1.62
3.05
3.6
2.8
2.4
2.4
mmol/l
0.17
62
423
32
171
1.97
2.98
3.1
2.1
—
—
—
0
0
20
90
2.30
2.86
1.7
1.5
—
—
—
0
0
67
453
1.60
2.82
1.7
1.7
—
—
—
0
0
53
338
1.68
2.80
1.8
1.6
—
—
—
0
0
130
1016
1.47
2.80
3.8
3.3
—
—
—
0
0
162
1321
1.45
2.79
4.1
3.5
0.0
0.0
estimate
0.00
35
246
159
1292
1.45
2.79
4.1
3.5
0.0
0.0
estimate
0.00
34
257
114
869
1.48
2.78
2.8
2.3
—
—
—
0
0
53
339
1.67
2.77
2.0
1.4
—
—
—
0
0
305
2857
2.15
2.77
17.1
12.4
—
—
—
0
0
98
728
1.50
2.71
2.9
2.9
—
—
—
0
0
36
209
1.81
2.63
5.1
2.8
67.6
66.6
g/l
0.37
36
190
159
1302
1.43
2.63
5.8
4.7
0.0
0.0
estimate
0.00
36
253
16
68
2.42
2.60
2.9
2.5
1.2
1.5
mg/l
1.60
16
61
59
395
1.60
2.58
3.2
2.3
15.1
13.7
umol/l
0.66
52
362
308
2912
2.17
2.45
12.5
10.1
28.4
26.5
u/l
0.97
299
2803
22
112
2.03
2.37
3.7
3.2
—
—
—
0
0
88
657
1.47
2.34
7.2
7.1
—
—
—
0
0
76
554
1.49
2.27
2.2
2.5
4.8
4.9
e6/l
0.01
64
490
13
54
2.47
2.22
1.4
1.7
—
—
—
0
0
119
948
1.40
2.21
3.7
3.6
78.4
65.9
e6/l
0.12
85
659
25
137
1.89
2.20
10.7
11.8
—
—
—
0
0
112
883
1.41
2.20
2.8
2.4
58.9
54.5
u/l
0.75
102
811
255
2313
1.48
2.20
22.4
16.4
13.7
13.7
%
0.13
249
2276
100
776
1.42
2.14
2.2
2.1
169.8
281.4
u/l
0.65
89
732
8
25
3.25
2.11
4.8
2.6
—
—
—
0
0
9
31
2.96
2.09
1.4
1.3
—
—
—
0
0
52
356
1.55
2.08
3.3
2.3
2.3
2.3
g/l
0.23
46
330
5
10
5.06
2.08
1.0
1.1
—
—
—
0
0
17
83
2.11
2.05
1.0
1.2
—
—
—
0
0
6
15
4.05
2.05
1.0
1.9
—
—
—
0
0
90
691
1.42
2.04
5.2
4.5
—
—
—
0
0
8
26
3.13
2.02
1.1
1.3
—
—
—
0
0
9
32
2.86
2.01
1.9
1.3
122.8
0.5
nmol/l
—
9
27
30
180
1.73
2.00
1.2
1.3
—
—
—
0
0
74
550
1.45
1.99
2.1
1.9
—
—
—
0
0
9
33
2.78
1.94
1.1
1.2
—
—
—
0
0
33
206
1.67
1.92
3.1
4.3
0.5
0.4
%
—
6
44
65
475
1.46
1.91
1.8
1.6
1406.0
1215.3
nmol/l
0.84
42
356
140
1171
1.34
1.85
3.5
2.7
137.1
112.9
ug/l
0.49
128
1079
6
17
3.58
1.84
5.2
2.7
—
—
—
0
0
21
116
1.87
1.83
2.3
2.4
—
—
—
0
0
16
80
2.05
1.83
4.6
3.1
—
—
—
0
0
48
334
1.51
1.79
1.3
1.3
—
—
—
0
0
269
2497
1.46
1.76
6.2
5.5
40.2
39.5
mmol/mol
0.55
247
2328
78
600
1.40
1.73
1.2
1.2
0.6
1.7
u/ml
1.67
17
159
8
30
2.71
1.73
1.9
1.3
—
—
—
0
0
7
24
2.96
1.73
2.0
1.0
—
—
—
0
0
281
2634
1.50
1.72
5.1
4.4
6.0
5.9
mmol/l
0.98
257
2419
24
142
1.75
1.70
9.9
10.6
24.1
24.5
mmol/l
0.29
24
134
51
365
1.47
1.67
1.3
1.4
680.0
470.5
titre
0.23
13
80
30
190
1.64
1.67
1.3
1.5
—
—
—
0
0
8
31
2.62
1.67
1.3
1.3
—
—
—
0
0
30
191
1.63
1.64
1.2
1.2
97.5
146.7
iu/ml
—
6
66
35
232
1.57
1.63
3.4
4.3
0.7
0.8
%
—
7
69
33
216
1.59
1.62
3.4
4.4
0.0
0.1
%
—
7
59
52
377
1.45
1.60
2.4
2.2
—
—
—
0
0
33
218
1.57
1.56
1.6
1.4
—
—
—
0
0
92
739
1.34
1.55
1.7
1.7
1.6
1.4
mmol/l
0.89
79
632
85
675
1.35
1.55
2.9
2.8
10310.2
8727.9
umol/l
0.08
74
588
39
269
1.51
1.53
2.5
4.5
4.1
24.6
ug/l
0.70
31
219
36
244
1.53
1.53
8.9
10.6
120.2
120.9
g/l
0.08
36
235
14
72
1.99
1.51
2.0
1.8
5.2
7.4
iu/l
—
6
25
32
212
1.57
1.50
10.4
9.5
—
—
—
0
0
19
110
1.77
1.46
1.5
1.6
—
—
—
0
0
7
28
2.53
1.46
2.0
1.3
—
—
nmol/l
—
0
0
31
206
1.56
1.44
1.8
2.4
2.4
6.0
ug/l
4.67
22
188
313
3029
1.98
1.44
28.1
19.9
250.7
250.7
e9/l
0.00
307
2955
46
334
1.44
1.41
3.3
2.3
26.0
23.6
%
0.61
37
288
283
2679
1.45
1.40
4.8
4.3
1.4
1.5
mmol/l
1.34
260
2475
66
512
1.36
1.39
1.6
1.7
446.0
449.9
pmol/l
0.04
48
435
96
789
1.31
1.37
4.8
3.9
3.6
8.7
mg/mmol
2.72
64
491
313
3033
1.94
1.37
28.1
19.9
4.5
4.5
e12/l
0.43
304
2954
313
3034
1.93
1.35
28.2
19.9
7.0
6.7
e9/l
1.34
305
2953
37
260
1.48
1.34
9.0
10.1
96.2
95.7
%
0.43
37
253
9
42
2.17
1.34
2.3
3.0
—
—
—
0
0
89
727
1.31
1.33
3.6
3.1
—
—
—
0
0
284
2697
1.43
1.31
4.8
4.3
4.7
4.7
mmol/l
0.18
265
2508
9
44
2.07
1.28
1.4
1.3
—
—
—
0
0
30
205
1.51
1.25
3.6
4.5
0.0
0.0
%
—
6
49
6
25
2.43
1.25
1.8
1.5
—
—
—
0
0
91
752
1.29
1.24
3.9
3.2
585.5
227.0
mg/l
0.27
62
482
23
148
1.60
1.24
1.3
1.3
—
—
—
0
0
6
26
2.33
1.19
1.0
1.2
0.4
1.3
promille
—
6
19
73
591
1.30
1.16
4.0
3.5
—
—
—
0
0
5
20
2.52
1.15
1.0
1.2
—
—
—
0
0
97
816
1.27
1.15
3.7
3.0
8.0
7.7
mmol/l
0.26
82
678
15
88
1.74
1.13
4.8
10.2
2.1
1.5
%
0.62
15
82
7
138
0.50
1.12
1.3
1.7
—
—
—
0
0
7
31
2.29
1.11
1.0
1.2
—
—
—
0
0
18
277
0.63
1.10
1.1
1.3
—
—
—
0
0
35
254
1.42
1.10
1.7
1.5
—
—
—
0
0
5
21
2.40
1.09
1.0
1.3
1.9
1.8
mmol/l
—
5
21
29
204
1.46
1.07
1.1
1.1
—
—
—
0
0
7
34
2.08
1.03
1.7
1.3
—
—
—
0
0
14
83
1.72
1.03
5.0
10.7
0.9
0.9
%
0.32
14
78
10
53
1.92
1.02
3.0
3.1
3.3
4.5
e9/l
—
10
53
286
2742
1.37
1.02
5.5
4.8
2.8
2.8
mmol/l
0.13
265
2528
30
215
1.44
1.02
3.9
3.4
—
—
—
0
0
5
23
2.19
0.98
4.6
2.1
29.6
17.1
ug/l
—
5
23
10
54
1.88
0.97
3.2
3.6
56.1
57.8
%
—
10
54
7
36
1.96
0.97
1.0
2.6
—
—
—
0
0
117
1024
1.22
0.96
5.2
3.6
20.4
39.6
ng/l
2.40
76
687
10
55
1.84
0.93
1.1
1.2
—
—
—
0
0
6
29
2.09
0.89
1.2
3.1
—
—
—
0
0
8
42
1.93
0.89
2.0
1.7
—
—
—
0
0
10
56
1.81
0.88
1.3
1.3
—
—
—
0
0
33
248
1.37
0.88
2.5
1.8
364.0
369.0
nmol/l
0.06
33
227
67
557
1.26
0.87
1.7
1.4
3.0
2.4
g/l
0.59
42
346
84
717
1.23
0.87
4.3
3.8
0.0
0.0
estimate
0.00
36
252
88
756
1.23
0.85
3.3
2.7
—
—
—
0
0
58
476
1.27
0.84
1.2
1.3
20.4
29.4
iu/ml
0.46
11
154
28
207
1.39
0.82
2.4
2.5
67.0
72.1
e9/l
0.37
21
159
10
58
1.75
0.80
3.0
4.1
—
—
—
0
0
14
90
1.58
0.79
1.7
1.4
325.4
270.0
miu/ml
—
5
46
36
280
1.32
0.78
1.8
2.7
2.0
1.8
%
0.38
28
256
27
201
1.37
0.77
1.7
2.2
9.6
13.1
nmol/l
1.49
22
183
6
34
1.78
0.76
2.0
1.6
29.7
32.6
pg
—
6
34
270
2593
1.25
0.75
4.4
3.8
1.4
1.3
mmol/l
1.35
248
2383
7
38
1.86
0.74
2.0
3.4
—
—
—
0
0
32
248
1.32
0.72
4.2
4.4
—
—
—
0
0
74
641
1.20
0.67
3.8
4.8
—
—
—
0
0
7
44
1.60
0.65
1.4
1.2
—
—
—
0
0
14
95
1.50
0.65
3.5
2.7
—
—
—
0
0
5
30
1.68
0.61
4.4
3.4
2.3
3.2
nmol/l
—
5
30
30
237
1.29
0.61
4.3
3.5
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
0.8
—
0
7
8
52
1.55
0.60
2.6
2.2
—
—
—
0
0
25
193
1.32
0.59
3.9
3.9
67.2
83.1
ng/l
0.89
25
175
6
35
1.73
0.58
1.0
1.9
90.4
89.8
%
—
6
35
14
98
1.45
0.57
1.5
1.3
—
4.4
—
0
6
6
37
1.63
0.56
1.2
1.2
—
—
—
0
0
25
197
1.29
0.53
2.0
2.7
3.9
4.1
e9/l
0.17
16
159
6
98
0.60
0.53
4.8
9.0
—
—
—
0
0
6
40
1.51
0.52
1.5
1.1
—
—
—
0
0
10
67
1.51
0.50
1.5
1.1
—
—
—
0
0
7
45
1.57
0.49
1.0
1.1
—
—
—
0
0
7
45
1.57
0.49
1.0
1.1
—
—
—
0
0
7
45
1.57
0.49
1.1
1.0
—
—
—
0
0
7
47
1.50
0.48
4.7
15.7
103.3
104.8
mmol/l
—
7
42
7
47
1.50
0.48
4.7
15.7
9.6
10.8
mmol/l
—
7
42
38
322
1.20
0.45
2.2
1.8
—
—
—
0
0
88
801
1.14
0.43
4.9
4.6
1.8
2.2
ug/l
0.62
75
715
39
333
1.19
0.43
1.8
2.3
95.0
137.1
ug/g
0.64
33
266
10
70
1.44
0.42
1.1
1.2
—
—
—
0
0
8
58
1.39
0.42
2.0
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
12
88
1.38
0.40
1.3
1.2
6.0
9.5
u/l
—
7
70
8
60
1.34
0.40
5.5
2.4
23.1
24.6
mmol/l
—
8
52
18
142
1.28
0.39
1.9
3.0
0.4
0.1
e6/l
0.40
18
137
5
36
1.39
0.38
1.4
2.9
108.0
105.8
mmol/l
—
5
36
5
36
1.39
0.38
1.4
2.9
4.2
4.1
mmol/l
—
5
36
5
36
1.39
0.38
1.4
2.9
—
—
—
0
0
9
67
1.35
0.38
2.6
3.1
40.1
35.0
umol/l
—
9
53
9
69
1.31
0.37
9.7
12.4
1.1
1.3
mmol/l
—
9
58
6
42
1.44
0.35
4.8
2.3
—
—
—
0
0
7
52
1.35
0.31
1.3
1.6
—
—
—
0
0
7
99
0.70
0.31
5.6
4.3
—
—
—
0
0
69
633
1.11
0.31
2.5
2.0
2.5
3.1
mg/l
1.95
60
543
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
14
174
0.80
0.30
2.7
2.3
—
—
—
0
0
7
57
1.23
0.29
5.1
3.3
—
—
—
0
0
37
328
1.14
0.28
1.2
1.3
—
—
—
0
0
26
225
1.17
0.27
6.2
4.3
—
—
—
0
0
65
604
1.10
0.23
1.7
1.5
20.1
20.7
nmol/l
0.12
58
520
51
468
1.11
0.23
1.2
1.3
7.0
8.4
u/ml
0.12
16
183
5
39
1.29
0.23
1.2
1.4
—
—
—
0
0
32
286
1.13
0.22
1.5
1.7
—
—
—
0
0
5
40
1.25
0.22
1.4
3.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
6
49
1.23
0.20
6.8
3.3
6.9
7.4
mmol/l
—
6
49
6
50
1.20
0.20
1.5
1.3
—
—
—
0
0
7
58
1.21
0.18
2.4
1.4
—
—
—
0
0
15
129
1.17
0.17
1.1
1.1
—
—
—
0
0
8
69
1.16
0.16
1.4
1.9
—
—
—
0
0
8
72
1.11
0.16
7.3
4.3
—
—
—
0
0
9
78
1.16
0.15
1.3
1.5
—
—
—
0
0
9
78
1.16
0.15
1.3
1.5
—
—
—
0
0
9
78
1.16
0.15
1.6
1.6
—
—
—
0
0
12
103
1.17
0.14
1.2
1.6
—
—
—
0
0
12
103
1.17
0.14
1.2
1.6
—
—
—
0
0
12
103
1.17
0.14
1.2
1.6
—
—
—
0
0
60
577
1.05
0.09
4.7
3.6
1.0
1.0
kg/l
—
9
75
14
126
1.12
0.09
5.1
3.2
—
—
—
0
0
11
98
1.13
0.07
1.2
1.6
—
—
—
0
0
16
147
1.09
0.07
7.6
10.3
26.3
24.9
mmol/l
0.96
16
138
101
1030
0.97
0.06
3.4
2.7
—
—
—
0
0
11
120
0.91
0.05
1.0
1.1
—
—
—
0
0
11
101
1.09
0.04
3.3
2.4
583.3
3410.4
u/l
—
5
35
14
132
1.06
0.02
2.9
2.5
1.5
1.3
%
0.19
14
132
16
152
1.06
0.02
5.8
3.4
131.8
130.2
g/l
0.10
16
152
12
113
1.06
0.02
5.0
3.5
26.7
24.9
mmol/l
1.05
12
113
15
157
0.95
0.01
3.8
7.1
—
—
—
0
0
26
267
0.97
0.01
1.5
1.4
—
—
—
0
0
46
466
0.98
0.00
2.8
2.9
0.7
0.8
ug/l
0.31
30
296
19
185
1.03
0.00
1.4
1.4
—
—
—
0
0
10
104
0.96
0.00
1.2
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
1.6
—
0
7
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
14.8
—
0
7
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
10944.8
—
0
5
0
6
0.00
0.00
0.0
5.7
—
6.0
—
0
6
0
6
0.00
0.00
0.0
1.0
—
3.4
—
0
6
8
89
0.90
0.00
1.3
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
9
89
1.01
0.00
1.2
1.3
—
—
—
0
0
5
56
0.89
0.00
1.4
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
3.8
—
54.1
—
0
9
8
80
1.00
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
5
57
0.88
0.00
2.4
4.4
12.4
24.1
mg/l
—
5
34

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_OROPHA_OTHER and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_OROPHA_OTHER 1.256 [0.99, 1.6] 0.063
Birth year 0.996 [0.99, 1.01] 0.452

During the follow-up period (1.1.1998 — 31.12.2019), 117 out of 834 females with CD2_BENIGN_OROPHA_OTHER died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_OROPHA_OTHER 1.677 [1.28, 2.2] < 0.001
Birth year 0.986 [0.98, 1.0] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 137 out of 733 males with CD2_BENIGN_OROPHA_OTHER died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_OROPHA_OTHER.

N-year risk Females Males
1 0.14% 0.328%
5 0.857% 1.893%
10 2.044% 4.924%
15 3.593% 9.149%
20 6.503% 14.734%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_OROPHA_OTHER – Benign neoplasm: Other parts of oropharynx

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data